ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6654
-0.14%
Brent Oil
82.845
1.06%
Bitcoin
69,541.80
1.50%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pluri Inc (PLUR)

  7. Pluri Inc (PLUR) Noticias

PLUR

Pluri (PLUR)

Pluri Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PLUR
FechaHoraFuenteTítuloSímboloCompañía
20/05/202406:00GlobeNewswire Inc.Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial ScaleNASDAQ:PLURPluri Inc
09/05/202415:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLURPluri Inc
09/05/202415:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
02/05/202406:00GlobeNewswire Inc.Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer TreatmentNASDAQ:PLURPluri Inc
08/04/202406:00GlobeNewswire Inc.Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New MethodNASDAQ:PLURPluri Inc
28/03/202406:15GlobeNewswire Inc.Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesNASDAQ:PLURPluri Inc
27/03/202406:00GlobeNewswire Inc.Pluri Inc. Announces 1-for-8 Reverse Share SplitNASDAQ:PLURPluri Inc
21/03/202406:00GlobeNewswire Inc.Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportNASDAQ:PLURPluri Inc
19/03/202403:00GlobeNewswire Inc.Engage with Pluri's Talent: Exciting Conference Appearances AheadNASDAQ:PLURPluri Inc
14/03/202406:00GlobeNewswire Inc.Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingNASDAQ:PLURPluri Inc
11/03/202406:00GlobeNewswire Inc.Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationNASDAQ:PLURPluri Inc
06/03/202406:00GlobeNewswire Inc.Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardNASDAQ:PLURPluri Inc
28/02/202406:00GlobeNewswire Inc.Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsNASDAQ:PLURPluri Inc
14/02/202416:43Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PLURPluri Inc
13/02/202415:34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLURPluri Inc
25/01/202415:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
24/01/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
23/01/202401:00GlobeNewswire Inc.Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisNASDAQ:PLURPluri Inc
21/12/202306:00GlobeNewswire Inc.Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine AddictionNASDAQ:PLURPluri Inc
21/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PLURPluri Inc
12/09/202315:07Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PLURPluri Inc
12/09/202315:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PLURPluri Inc
16/08/202306:00GlobeNewswire Inc.Pluri’s PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow TransplantationNASDAQ:PLURPluri Inc
13/07/202301:00GlobeNewswire Inc.Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of DirectorsNASDAQ:PLURPluri Inc
11/07/202301:00GlobeNewswire Inc.U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation SyndromeNASDAQ:PLURPluri Inc
27/04/202306:00GlobeNewswire Inc.Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based ProductsNASDAQ:PLURPluri Inc
13/03/202307:00GlobeNewswire Inc.Israel’s Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employment Award for its Commitment to Gender Diversity and Pay EquityNASDAQ:PLURPluri Inc
22/12/202206:00GlobeNewswire Inc.Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture Proof of ConceptNASDAQ:PLURPluri Inc
15/12/202215:05GlobeNewswire Inc.Pluri Prices $8.2 million Private Placement Offerings Priced At-The-Market Under Nasdaq RulesNASDAQ:PLURPluri Inc
10/11/202206:00GlobeNewswire Inc.Pluri wins BioTech Breakthrough Cell Innovation of the Year AwardNASDAQ:PLURPluri Inc
 Showing the most relevant articles for your search:NASDAQ:PLUR

Su Consulta Reciente

BOV
ELETG290
ELETG290 Ex:28,6
TSXV
CLIC
Comet Lithium
USOTC
SCRRF
Schroder Real Return (CE)
UNSW3
MRFETH
Mr F was here
BOV
LJQQ1
Lojas Quero-Quero ON
USOTC
UURAF
Ucore Rare Metals (QX)
BIT
F35382
Vontobel Financial Produ...
COIN
POGGUST
POG Coin [Polygonum]
BIT
VIXL
Wisdomtree S&p 500 Vix S...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados